Does RAMUCIRUMAB Cause Thrombotic microangiopathy? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Thrombotic microangiopathy have been filed in association with RAMUCIRUMAB (CYRAMZA). This represents 0.6% of all adverse event reports for RAMUCIRUMAB.
30
Reports of Thrombotic microangiopathy with RAMUCIRUMAB
0.6%
of all RAMUCIRUMAB reports
5
Deaths
24
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From RAMUCIRUMAB?
Of the 30 reports, 5 (16.7%) resulted in death, 24 (80.0%) required hospitalization, and 3 (10.0%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
Yes, Thrombotic microangiopathy is listed as a known adverse reaction in the official FDA drug label for RAMUCIRUMAB.
What Other Side Effects Does RAMUCIRUMAB Cause?
Malignant neoplasm progression (743)
Death (492)
Interstitial lung disease (269)
Febrile neutropenia (229)
Neutropenia (229)
Decreased appetite (187)
Diarrhoea (186)
Hypertension (175)
Pyrexia (161)
Nausea (160)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which RAMUCIRUMAB Alternatives Have Lower Thrombotic microangiopathy Risk?
RAMUCIRUMAB vs RANEXA
RAMUCIRUMAB vs RANIBIZUMAB
RAMUCIRUMAB vs RANIMUSTINE
RAMUCIRUMAB vs RANITIDINE
RAMUCIRUMAB vs RANITIDINE\RANITIDINE